immunology of transplantation part 3 W3 Flashcards
features of chronic rejection?
progressive renal dysfunction
interstitial fibrosis and vascular disease on renal biopsy
differential diagnosis of chronic rejection?
recurrent disease (membranous, MCGN)
obstruction (ultrasound)
renal artery stenosis (doppler of renal artery +/- MRI angiography)
features of chronic rejection
recurrent crescentic nephritis
recurrent diabetic nephropathy
interstitial fibrosis
vasculopathy
pathogenesis of chronic rejection?
increased HLA mismatch
previous acute rejection
poor drug compliance
prolonged cold ischaemia time of kidney prior to surgery
factors promoting graft failure?
delayed graft function
cytomegalovirus (CMV) infection
age of donor and donor disease
poor blood pressure control
proteinuria
management of chronic rejection?
no specific treatment
most patients eventually require dialysis and further transplants
optimise immunosuppression
proactive treatment of BP, lipids, proteinuria etc (statins, ACEis)
infective risks of immunosuppression - bacterial? how is this prevented?
UTI, chest infection
give prophylactic cotrimoxazole
infective risks of immunosuppression - viral? how is this prevented?
CMV, herpes virus, parvo virus, BK virus (cause renal dysfunction)
give prophylactic valganciclovir if recipient is CMV -ve and donor CMV +ve
infective risks of immunosuppresion other than bacterial/viral?
TB
BK virus infection features?
renal cells have abnormally large nuclei
BK virus infection treatment?
reduce immunosuppression to facilitate anti-viral immunity
tumour risks of immunosuppression?
incidence of all cancers increased
skin cancers common
post transplant lymphoproliferative disorder (PTLD) - secondary to infection with
prophylaxis for skin cancer risk? (tumour risks of immunosuppression)
UV block, avoid sun, skin surveillance
treatment for post transplant lymphoproliferative disorder (PTLD)?
reduce immunosuppression, may need chemotherapy/surgery
side effects of immunosuppressive drugs
calcineurin inhibitors are nephrotoxic (eg tacrolimus)
increased risk of diabetes (steroids, tacrolimus)
hypertension (steroids and CNI)
osteoporosis (steroids)